Wave Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Wave Life Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. 

CEO
Paul B. Bolno
CEOPaul B. Bolno
Employees
317
Employees317
Headquarters
Singapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded
2012
Founded2012
Employees
317
Employees317

WVE Key Statistics

Market cap
1.38B
Market cap1.38B
Price-Earnings ratio
-6.81
Price-Earnings ratio-6.81
Dividend yield
Dividend yield
Average volume
4.39M
Average volume4.39M
High today
$7.28
High today$7.28
Low today
$7.10
Low today$7.10
Open price
$7.19
Open price$7.19
Volume
2.55M
Volume2.55M
52 Week high
$21.73
52 Week high$21.73
52 Week low
$5.02
52 Week low$5.02

Stock Snapshot

The current Wave Life Sciences(WVE) stock price is $7.19, with a market capitalization of 1.38B. The stock trades at a price-to-earnings (P/E) ratio of -6.81.

On 2026-05-10, Wave Life Sciences(WVE) stock moved within a range of $7.10 to $7.28. With shares now at $7.19, the stock is trading +1.3% above its intraday low and -1.2% below the session's peak.

Trading volume for Wave Life Sciences(WVE) stock has reached 2.55M, versus its average volume of 4.39M.

Over the past 52 weeks, Wave Life Sciences(WVE) stock has traded between a high of $21.73 and a low of $5.02.

Over the past 52 weeks, Wave Life Sciences(WVE) stock has traded between a high of $21.73 and a low of $5.02.

WVE News

Simply Wall St 3d
Surging Q1 Revenue And Narrower Losses Might Change The Case For Investing In Wave

Wave Life Sciences Ltd. recently reported first-quarter 2026 results, with sales rising to US$38.25 million from US$9.18 million a year earlier and net loss nar...

Surging Q1 Revenue And Narrower Losses Might Change The Case For Investing In Wave

Analyst ratings

100%

of 18 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own WVE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.